Lead Bioinformatician - Biomarker and Therapeutic Target Discovery
Natera- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
Employment Type: Full time
At Lilly, we unite caring with discovery to make life better for people around the world. Headquartered in Indianapolis, Indiana, we are a global healthcare leader with over 35,000 employees dedicated to discovering and delivering life-changing medicines. Our mission extends beyond pharmaceuticals—we are committed to improving disease management, fostering scientific innovation, and giving back to communities through philanthropy and volunteerism.
Lilly’s Neuroscience Research team is at the forefront of developing cutting-edge therapies and diagnostics for brain disorders. We seek an accomplished biomarker expert to lead our efforts in biomarker discovery and validation, enabling the diagnosis and treatment of neurodegenerative conditions. As Vice President (or Associate Vice President), you will drive the strategic and technical development of biomarker assays that are instrumental in the advancement of our neuroscience pipeline. Biomarkers play a crucial role in clinical trials, providing insights into patient selection, therapeutic efficacy, safety, and mechanisms of action.
Join Lilly in shaping the future of neuroscience by advancing biomarker-driven precision medicine. If you are a leader in biomarker discovery looking to make a meaningful impact, we invite you to apply.
Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form.
Develops and delivers prescription medicines globally
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.